CrossrefInfokarte
Evaluating the Role of Disease Duration in Systemic Therapy Response Among Patients with Moderate-to-Severe Psoriasis
Psoriasis: Targets and Therapy · 2025-10 · Volume 15 · 513-525
DOI: 10.2147/ptt.s544568 ↗Abstract
Kein Abstract verfügbar.
EUVIMED